Hillbom, Matti

Karttunen, Vesa

Reggiani, Monica

Riutta, Asko

Uchiyama, Shinichiro

Wartiovaara-Kautto, Ulla

Stroke Research and Treatment

PubMed

Obstructive sleep apnoea (OSA) carries an increased risk of ischaemic stroke, but the underlying mechanism is not clear. As right-to-left shunting can occur through a patent foramen ovale (PFO) during periods of apnoea, we investigated nocturnal changes in fibrinolytic activity and platelet function in subjects who had OSA with or without PFO and in controls. We determined plasminogen activator inhibitor 1 (PAI-1) activity and antigen and platelet activation parameters. The severity of OSA was verified by polygraphy and PFO was detected by ear oximetry. We found a higher PAI-1 activity and antigen and a lower ratio of 2,3-dinor-PGF1α to 2,3-dinor-TXB2 in the subjects with OSA than in the controls. Linear regression analysis showed the apnoea-hypopnoea index (β-coefficient, 0.499; P=0.032) and PFO (β-coefficient, 0.594; P=0.015) to be associated independently with PAI-1 activity in the morning, while the increment in PAI-1:Ag from evening to morning was significantly associated with the presence of PFO (rs=0.563, P=0.002). Both OSA and PFO reduce fibrinolytic activity during nocturnal sleep. We hypothesize that subjects having both OSA and PFO may develop a more severe prothrombotic state during sleep than those having either OSA or PFO alone

Monica Reggiani

Vesa Karttunen

Ulla Wartiovaara-Kautto

Asko Riutta

Shinichiro Uchiyama

Matti Hillbom

Directory of Open Access Journals

Fibrinolytic Activity and Platelet Function in Subjects with Obstructive Sleep Apnoea and a Patent Foramen Ovale: Is There an Option for Prevention of Ischaemic Stroke?

Helsingin yliopiston digitaalinen arkisto

Obstructive sleep apnoea (OSA) carries an increased risk of ischaemic stroke, but the underlying mechanism is not clear. As right-to-left shunting can occur through a patent foramen ovale (PFO) during periods of apnoea, we investigated nocturnal changes in fibrinolytic activity and platelet function in subjects who had OSA with or without PFO and in controls. We determined plasminogen activator inhibitor 1 (PAI-1) activity and antigen and platelet activation parameters. The severity of OSA was verified by polygraphy and PFO was detected by ear oximetry. We found a higher PAI-1 activity and antigen and a lower ratio of 2,3-dinor-PGF1αto 2,3-dinor-TXB2in the subjects with OSA than in the controls. Linear regression analysis showed the apnoea-hypopnoea index (β-coefficient, 0.499;P=0.032) and PFO (β-coefficient, 0.594;P=0.015) to be associated independently with PAI-1 activity in the morning, while the increment in PAI-1:Ag from evening to morning was significantly associated with the presence of PFO (rs=0.563,P=0.002). Both OSA and PFO reduce fibrinolytic activity during nocturnal sleep. We hypothesize that subjects having both OSA and PFO may develop a more severe prothrombotic state during sleep than those having either OSA or PFO alone.</jats:p

Crossref

2003WorldHealthOrganization(WHO)/InternationalSociety of Hypertension (ISH) statement on management of hypertension,”

Activation-independent platelet adhesion and aggregation under elevated shear stress,”

andN.F.Jarmukli,“Prevalenceofpatentforamenovaleandits contribution to hypoxemia in patients with obstructive sleep apnea,”

Association between sleep apnea severity and blood coagulability: treatment eﬀects of nasal continuous positive airway pressure,” Sleep and Breathing,

Continuous measurement of shear-induced platelet aggregation,”

e s t ,H .S e g a l ,P .H a r r i s o n ,a n dJ .S t r a d l i n g ,“ P l a t e l e t function (measured by Platelet Function Analyser—100)

Ear oximetry: a noninvasive method for detection of patent foramen ovale: a study comparing dye dilution method and oximetry with contrast transesophageal echocardiography,”

Eﬀects of alcohol and the evening meal on shear-induced platelet aggregationandurinaryexcretionofprostanoids,”Alcoholand Alcoholism,

Fibrinogen levels and obstructive sleep apnea in ischemic stroke,”

H.Kimura,M.Niijima,Y.Abeetal.,“Compensatoryexcretion of prostacyclin and thromboxane metabolites in obstructive sleep apnea syndrome,”

Hematologic ramiﬁcations of patent foramen ovale—role of hypercoagulable state,”

Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease,”

High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a ﬁrst acute myocardial infarction in both men and women: evidence for the ﬁbrinolytic system as an independent primary risk factor,”

Hypoxia induces transcription of the plasminogen activator inhibitor1 gene through genistein-sensitive tyrosine kinase pathways in vascular endothelial cells,”

In vivo platelet activation isincreased duringsleep in patients with obstructive sleep apnea syndrome,”

o l k ,T .K a r a ,a n dV .K .S o m e r s ,“ S l e e p - d i s o r d e r e d breathing and cardiovascular disease,”

Obstructive sleep apnea as a risk factor for stroke and death,” The New England

Obstructive sleep apnea can be provocative for right-to-left shunting through a patent foramen ovale,”

Obstructive sleep apnea,”

Obstructive sleep apnoea and stroke,”

Obstructive sleep apnoea syndrome—an oxidative stress disorder,”

PAI-1 and atherothrombosis,”

PFO and rightto-left shunting in patients with obstructive sleep apnoea,”

Plasminogen activator inhibitor-1 in patients with ischemic stroke.,”

Platelet activation, epinephrine, and blood pressure in obstructive sleep apnea syndrome,”

Platelet function and ﬁbrinolytic activity in hypertensive and normotensive sleep apnea patients,”

Platelet function in patients with obstructive sleep apnoea syndrome,”

Platelets synthesize large amounts of active plasminogen activator inhibitor 1,”

Pleiotropic functions of plasminogen activator

Populationbased study of the relationship between patent foramen ovale andcerebrovascularischemicevents,”MayoClinicProceedings,

Shearinduced platelet aggregation in cerebral ischemia,”

Signiﬁcant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause,”

Sleep-related breathing disorders and risk of

Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure: a preliminary investigation,”

The eﬀects of nasal continuous positive airway pressure on platelet activation in obstructive sleep apnea syndrome,”

Urinary excretion of prostanoids during sleep in obstructive sleep apnoea patients,”

http://downloads.hindawi.com/journals/srt/2012/945849.pdf

Fibrinolytic Activity and Platelet Function in Subjects with Obstructive Sleep Apnoea and a Patent Foramen Ovale: Is There an Option for Prevention of Ischaemic Stroke?

Abstract

Similar works

Full text

Available Versions

Directory of Open Access Journals

Helsingin yliopiston digitaalinen arkisto

Crossref